Predictors for Outcomes in Patients with Severe ANCA-associated Glomerulonephritis who were Dialysis-dependent at Presentation: A Study of 89 Cases in a Single Chinese Center

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 5, 2013, Pages 515-521

  Li, Zhi Ying ^a,b,c,d,e   Gou, Shen Ju ^a,b,c,d,e   Chen, Min ^a,b,c,d,e   Zhao, Ming Hui ^a,b,c,d,e  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c Tsinghua University   (China)

^d BEIJING HOSPITAL   (China)

^e Ministry of Education   (China)

Author keywords

ANCA associated vasculitis; Dialysis; Mortality; Predictors

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADOLESCENT; ADULT; AGE; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CHINESE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; FEMALE; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TUBULE DISORDER; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLASMAPHERESIS; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CAUSE OF DEATH; CHINA; COHORT STUDIES; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY GLOMERULUS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876956598     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.09.005     Document Type: Article

References (26)

1. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1994, 37(2):187-192.
2. Booth A.D., Almond M.K., Burns A., Ellis P., Gaskin G., Neild G.H., et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003, 41(4):776-784.
3. Jayne D., Rasmussen N., Andrassy K., Bacon P., Tervaert J.W., Dadoniené J., et al. European Vasculitis Study Group: a randomized trial ofmaintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003, 349(1):36-44.
4. de Lind van Wijngaarden R.A., Hauer H.A., Wolterbeek R., Jayne D.R., Gaskin G., Rasmussen N., et al. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol 2007, 18(7):2189-2197.
5. Chen M., Yu F., Zhang Y., Zhao M.H. Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitis: a study of 426 patients from a single center. Postgrad Med J 2005, 81(961):723-727.
6. Jayne D.R., Gaskin G., Rasmussen N., Abramowicz D., Ferrario F., Guillevin L., et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007, 18(7):2180-2188.
7. Hauer H.A., Bajema I.M., van Houwelingen H.C., Ferrario F., Noël L.H., Waldherr R., et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 2002, 61(1):80-89.
8. Chang D.Y., Wu L.H., Liu G., Chen M., Kallenberg C.G., Zhao M.H. Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant 2012, 27(6):2343-2349.
9. Berden A.E., Ferrario F., Hagen E.C., Jayne D.R., Jennette J.C., Joh K., et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 2010, 21(10):1628-1636.
10. Abril A., Calamia K.T., Cohen M.D. The Churg-Strauss syndrome (allergic granulomatous angiitis): review and update. Semin Arthritis Rheum 2003, 33(2):106-114.
11. Ma Y.C., Zuo L., Chen J.H., Luo Q., Yu X.Q., Li Y., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006, 17(12):2937-2944.
12. Luqmani R.A., Bacon P.A., Moots R.J., Janssen B.A., Pall A., Emery P., et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994, 87(11):671-678.
13. Zhao M.H., Lockwood C.M. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods 1996, 197(1-2):121-130.
14. Bajema I.M., Hagen E.C., Hermans J., Noël L.H., Waldherr R., Ferrario F., et al. Project for ANCA-assay standardisation: kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 1999, 56(5):1751-1758.
15. Bajema I.M., Hagen E.C., Hansen B.E., Hermans J., Noël L.H., Waldherr R., et al. The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement. Nephrol Dial Transplant 1996, 11(10):1989-1995.
16. Jennette J.C. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003, 63(3):1164-1177.
17. Haubitz M., Schellong S., Göbel U., Schurek H.J., Schaumann D., Koch K.M., et al. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. Arthritis Rheum 1998, 41(10):1835-1844.
18. Guillevin L., Cordier J.F., Lhote F., Cohen P., Jarrousse B., Royer I., et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997, 40(12):2187-2198.
19. De Groot K., Harper L., Jayne D.R., Flores S.L.F., Gregorini G., Gross W.L., et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody associated vasculitis: a randomized trial. Ann Intern Med 2009, 150(10):670-680.
20. Chen M., Yu F., Zhang Y., Zou W.Z., Zhao M.H., Wang H.Y. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int 2005, 68(5):2225-2229.
21. Chen M., Cui Z., Zhao M.H. ANCA-associated vasculitis and anti-GBM disease: the experience in China. Nephrol Dial Transplant 2010, 25(7):2062-2065.
22. Chen M., Yu F., Wang S.X., Zou W.Z., Zhang Y., Zhao M.H., et al. Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis. Nephrol Dial Transplant 2007, 22(1):139-145.
23. Wang Y., Zhao M.H., Yu J., Xin G., Liu Y.C., Zhang Y.K., et al. The clinical and pathological characteristics of Chinese elderly patients with anti-neutrophil cytoplasmic autoantibodies associated small vessel vasculitis. Exp Gerontol 2004, 39(9):1401-1405.
24. Xin G., Zhao M.H., Wang H.Y. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in Chinese patients with clinically suspected vasculitis. Clin Diagn Lab Immunol 2004, 11(3):559-562.
25. Little M.A., Nightingale P., Verburgh C.A., Hauser T., De Groot K., Savage C., et al. Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 2010, 69(6):1036-1043.
26. Chen M., Yu F., Zhang Y., Zhao M.H. Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore) 2008, 87(4):203-209.